Online citations, reference lists, and bibliographies.

Peritoneal Cancer Index: A Prognostic Indicator Of Survival In Advanced Ovarian Cancer.

A. Tentes, G. Tripsiannis, S. Markakidis, C. Karanikiotis, G. Tzegas, G. Georgiadis, K. Avgidou
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
AIM The peritoneal cancer index (PCI) has been used for the detailed evaluation of the peritoneal spread in tumors of gastrointestinal origin and has been found to be a prognostic indicator of survival. The aim of this study was the identification of the significance of the peritoneal cancer index in advanced ovarian cancer. METHODS From 1990 to 2001, 60 women, mean age 65+/-10.84 (41-86), were treated for advanced ovarian cancer. The performance status (Karnofsky performance scale), age, prior surgery score (PSS), peritoneal cancer index (PCI), tumor volume, tumor grade, residual tumor, the presence of ascites, treatment with adjuvant chemotherapy, histopathologic subtype and FIGO stage were retrospectively correlated to survival using univariate model of statistical analysis. RESULTS Hospital mortality and morbidity were 11.7 and 16.7% respectively. The recurrence rate was 23.3%. Overall 5-year survival rate was 41% and mean survival 63+/-8 months. The peritoneal cancer index was related to survival (P=0.0253). The other favorable clinical prognostic indicators of survival were low grade and small volume tumors, treatment with adjuvant chemotherapy and complete cytoreductive surgery (P<0.05). CONCLUSIONS The peritoneal spread in advanced ovarian cancer can be assessed in detail using the peritoneal cancer index. It is a significant prognostic factor of survival and is useful in identifying subgroups.
This paper references
10.1093/annonc/4.suppl_4.S23
Advanced ovarian cancer. An overview of multi-variate analyses of prognostic variables with special reference to the role of cytoreductive surgery.
L. Levin (1993)
10.1053/EJSO.2000.0978
Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot.
N. van der Vange (2000)
10.1007/s10434-999-0727-7
Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy
P. Sugarbaker (1999)
Ovarian Carcinoma: A Multivariate Analysis of Prognostic Factors
K. Swenerton (1985)
10.1016/0277-5379(91)90011-2
Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.
J. Neijt (1991)
10.1016/0090-8258(92)90581-3
Peritoneal implant excision or ablation during cytoreductive surgery: The impact on survival
S. Eisenkop (1992)
10.1200/JCO.1996.14.11.2968
Natural history and prognosis of untreated stage I epithelial ovarian carcinoma.
F. Ahmed (1996)
10.1016/S0959-8049(98)00375-X
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment.
B. Berthet (1999)
10.1053/EJSO.2001.1152
Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.
G. Begossi (2002)
10.1007/978-1-4613-1247-5
Peritoneal Carcinomatosis: Principles of Management
P. Sugarbaker (1996)
10.1007/978-1-4613-1245-1_9
Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy.
P. Sugarbaker (1996)
10.1007/978-1-4613-1245-1
Peritoneal Carcinomatosis: Drugs and Diseases
P. Sugarbaker (1996)
10.1006/gyno.1993.1195
Survival determinants in patients with advanced ovarian cancer.
S. Ansell (1993)
10.1002/1097-0142(19931115)72:10<3007::aid-cncr2820721024>3.0.co;2-n
National survey of ovarian carcinoma VI: Critical assessment of Current International Federation of Gynecology and Obstetrics Staging System
H. Nguyen (1993)
10.1016/S0889-8588(18)30309-5
Prognostic factors in ovarian cancer.
M. Friedlander (1991)
10.1200/JCO.1991.9.7.1138
Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.
G. Omura (1991)
10.1097/00000658-199502000-00002
Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy
P. Sugarbaker (1995)
10.1007/978-1-4613-1247-5_23
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.
P. Jacquet (1996)
10.1046/j.1525-1438.1993.03020072.x
Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer
K. Bertelsen (1992)
10.1016/0090-8258(90)90099-7
A review: intraperitoneal cisplatin in the management of patients with ovarian cancer.
E. McClay (1990)
Prognostic factors in ovarian cancer
Friedlander Ml (1991)
10.1053/EJSO.2001.1044
Peritoneal mesothelioma proposal for a staging system.
G. Sebbag (2001)



This paper is referenced by
10.3109/07357907.2012.654871
Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–-Overview and Basics
B. L. Brücher (2012)
10.1016/J.REMNIE.2016.07.004
Peritoneal Cancer Index by (18)F-FDG PET/TC pre and post-hyperthermic intraperitoneal chemotherapy. Report of a case.
Jesús Rueda García (2016)
10.1016/j.jgyn.2015.06.020
[Anatomoclinical study of ovarian cancers in patients with history of hysterectomy for benign pathology].
Caroline Cornou (2016)
10.1097/GCO.0b013e32831f8f32
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer
Paul H Sugarbaker (2009)
10.1016/j.jss.2015.01.009
Photodynamic diagnosis for detection of peritoneal carcinomatosis.
Muhammad Qutayba Almerie (2015)
10.1007/978-0-387-48993-3_14
Staging and Scoring of Peritoneal Carcinomatosis
Stefan Käbler (2007)
10.1007/S12094-007-0118-0
Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals
F. C. Muñoz-Casares (2007)
10.1245/s10434-014-3599-4
Treatment of Microscopic Disease with Hyperthermic Intraoperative Intraperitoneal Chemotherapy After Complete Cytoreduction Improves Disease-Free Survival in Patients with Stage IIIC/IV Ovarian Cancer
P. Cascales-Campos (2014)
10.1245/s10434-020-08649-6
The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer
B. Jónsdóttir (2020)
10.1007/s12094-013-1053-x
Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin
F. Losa (2013)
10.1097/IGC.0000000000000327
Prognostic Significance of Sugarbaker’s Peritoneal Cancer Index for the Operability of Ovarian Carcinoma
Bjoern Lampe (2015)
10.1007/978-3-642-12130-2_10
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: An Ongoing Research Effort
Paul H Sugarbaker (2010)
10.1007/s00280-011-1646-4
Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study
Francisco Cristóbal Muñoz-Casares (2011)
10.1016/j.jmig.2016.03.025
Single-port or Classic Laparoscopy Compared With Laparotomy to Assess the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer.
L. Bresson (2016)
10.1097/IGC.0b013e3182a616a7
Accuracy and Reproducibility of the Peritoneal Cancer Index in Advanced Ovarian Cancer During Laparoscopy and Laparotomy
Sébastien Gouy (2013)
10.1016/j.ejso.2009.02.010
Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools.
H. A. M. Swellengrebel (2009)
10.1007/s00104-007-1426-1
Klinisches Staging der Peritonealkarzinose durch Scoringsysteme
J. Jähne (2007)
10.1007/s00261-016-0817-5
Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index
Daniel Diaz-Gil (2016)
10.1007/s11547-020-01170-6
Radiological assessment of Peritoneal Cancer Index on preoperative CT in ovarian cancer is related to surgical outcome and survival
Giacomo Avesani (2020)
10.1007/978-3-540-30760-0_13
Advances in clinical research and management of diffuse peritoneal mesothelioma.
M. Deraco (2007)
10.1093/annonc/mdt237
Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).
Denis Querleu (2013)
10.1177/030089161009600306
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Antonios-Apostolos K Tentes (2010)
10.1016/j.ajog.2009.10.856
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.
E. Chéreau (2010)
10.2217/14796694.4.5.671
Current status and future directions: management of colon cancer with peritoneal dissemination.
A. Kerscher (2008)
10.33878/2073-7556-2016-0-4-69-79
PERITONEAL COLORECTAL CARCINOMATOSIS. APPROACHES TO TREATMENT (REVIEW)
O. I. Sushkov (2016)
10.1016/J.BULCAN.2015.04.011
Prise en charge initiale du cancer de l’ovaire avancé : quelles sont les informations radiologiques, anatomo-pathologiques et chirurgicales importantes pour une stratégie thérapeutique optimale ?
Pierre-Etienne Heudel (2015)
10.1016/J.JGYN.2015.06.020
Étude anatomoclinique des cancers de l’ovaire chez les patientes aux antécédents d’hystérectomie pour pathologie bénigne
Cecile Cornou (2016)
10.1016/J.REMN.2016.02.004
Peritoneal Cancer Index mediante 18F-FDG PET/TC pre y poscirugía citorreductiva radical y quimioterapia intraperitoneal con hipertermia. A propósito de un caso
José Ramón García (2016)
10.1111/J.1525-1438.2006.00580.X
Long‐term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures
A. Tentes (2006)
Effektive Therapie bei peritonealen Neoplasmen mit niedrigem Peritoneal Cancer Index: Die Schwierigkeit der Diagnosesicherung
Enrico Maria Pasqual (2012)
10.1016/j.ygyno.2016.11.021
Optimizing the treatment of ovarian cancer: Neoadjuvant chemotherapy and interval debulking versus primary debulking surgery for epithelial ovarian cancers likely to have suboptimal resection.
S. Gill (2017)
10.1016/j.ejso.2017.11.003
Prognostic value of peritoneal cancer index in primary advanced ovarian cancer.
A. Llueca (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar